A Prospective Study to Compare the Clinical Outcomes, Pain and Patient Quality of Life for Hernia Patients
Launched by INTUITIVE SURGICAL · Mar 21, 2016
Trial Information
Current as of June 29, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • 1. Age 18 years and older
- • 2. All patients undergoing either an open, laparoscopic or robotic-assisted
- • 3. Incisional or Inguinal Hernia repair procedure
- • 4. Non-Emergent Incisional or Inguinal Hernia Repair cases
- Exclusion Criteria:
- • 1. Emergent Cases for both Incisional and Inguinal Hernia
- • 2. Incisional Hernia related to ostomy formation
- • 3. Incisional Hernia requiring component separation (determined pre-operatively or intraoperatively)
About Intuitive Surgical
Intuitive Surgical is a leading innovator in robotic-assisted minimally invasive surgery, dedicated to enhancing surgical outcomes through advanced technology. Renowned for its da Vinci Surgical System, the company develops cutting-edge surgical platforms that empower healthcare professionals to perform complex procedures with precision and control. Committed to clinical excellence and patient safety, Intuitive Surgical actively sponsors clinical trials to advance the understanding and application of robotic surgery across various specialties, ultimately aiming to improve patient care and surgical results worldwide.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Chicago, Illinois, United States
Nashville, Tennessee, United States
Baton Rouge, Louisiana, United States
Baltimore, Maryland, United States
Wilmington, North Carolina, United States
New York, New York, United States
Oakland, California, United States
Tulsa, Oklahoma, United States
Grand Rapids, Michigan, United States
Beverly Hills, California, United States
Carbondale, Illinois, United States
Louisville, Kentucky, United States
Nashville, California, United States
Celebration, Florida, United States
South Miami, Florida, United States
New Lenox, Illinois, United States
Memphis, Tennessee, United States
Dallas, Texas, United States
Patients applied
Trial Officials
Karl LeBlanc, MD
Study Chair
Surgeon Group of Baton Rouge
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials